Literature DB >> 20738166

The mechanisms of action of Tianhua(™) on antitumor activity in lung cancer cells.

Chien-Te Li1, Ching-Hsiung Lin, Te-Yu Kao, Ming-Fang Wu, Chin-Shui Yeh, Kun-Tu Yeh, Jiunn-Liang Ko.   

Abstract

CONTEXT: Tianhua (TH-R) is extracted from Trichosanthes kirilowii Maxim (Cucurbitaceae) containing trichosanthin, a traditional Chinese medicine, which has been locally reported to have good anticancer effects in vivo in both animal and human models. However, there have been several reports that trichosanthin has an anticancer effect involving apoptosis.
OBJECTIVE: To investigate other anticancer effects of TH-R, various tumorigenesis parameters were verified.
MATERIALS AND METHODS: Telomerase activity, anti-apoptosis, anti-migration and immunomodulatory activity were estimated by telomeric repeat amplification protocol assay (TRAP), flow cytometry, Boyden chamber assay and ELISA assay, respectively.
RESULTS: In our studies, we are the first to find that TH-R had a cytotoxic effect on lung cancer cells in MTS assays; it could change the cell cycle distribution of human lung cancer cells (A549 cell line) and induce apoptosis. Further anti-telomerase effects in human lung adenocarcinoma A549 cells using the TRAP assay were noted. TH-R also had an aggregation effect on peripheral blood lymphocytes, but no effect on stimulating peripheral lymphocytes to produce human interferon-γ(IFN-γ). TH-R could inhibit the migration, or metastatic ability, of A549 cells by Boyden chamber assay. In the oral feeding therapy of an in vivo mouse model, there was an initial inhibition of A549 cancer cell growth, but no statistical difference after one month of therapy. DISCUSSION AND
CONCLUSION: It has been proven that medicinal herbs such as Tianhua have positive effects against cancer through preventing or inhibiting the process of lung tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20738166     DOI: 10.3109/13880201003789432

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  10 in total

1.  A case of metastatic bladder cancer in both lungs treated with korean medicine therapy alone.

Authors:  Dong-Hyun Lee; Sung-Su Kim; Shin Seong; Chang-Ryoul Woo; Jae-Bok Han
Journal:  Case Rep Oncol       Date:  2014-07-30

2.  The anti-cancerous activity of recombinant trichosanthin on prostate cancer cell PC3.

Authors:  JinLong Li; Hui Li; ZhaoLi Zhang; NianYue Wang; YongChen Zhang
Journal:  Biol Res       Date:  2016-03-25       Impact factor: 5.612

3.  Trichosanthin enhances the antitumor effect of gemcitabine in non-small cell lung cancer via inhibition of the PI3K/AKT pathway.

Authors:  Naren Tuya; Yadi Wang; Lanmei Tong; Weishi Gao; Rong Yu; Liying Xue
Journal:  Exp Ther Med       Date:  2017-10-11       Impact factor: 2.447

Review 4.  Structural and Functional Investigation and Pharmacological Mechanism of Trichosanthin, a Type 1 Ribosome-Inactivating Protein.

Authors:  Wei-Wei Shi; Kam-Bo Wong; Pang-Chui Shaw
Journal:  Toxins (Basel)       Date:  2018-08-20       Impact factor: 4.546

Review 5.  Anti-tumor action of trichosanthin, a type 1 ribosome-inactivating protein, employed in traditional Chinese medicine: a mini review.

Authors:  Ou Sha; Junfei Niu; Tzi-Bun Ng; Eric Yu-Pang Cho; Xiaoyuan Fu; Wenqi Jiang
Journal:  Cancer Chemother Pharmacol       Date:  2013-02-03       Impact factor: 3.333

6.  Trichosanthin inhibits breast cancer cell proliferation in both cell lines and nude mice by promotion of apoptosis.

Authors:  Evandro Fei Fang; Chris Zhi Yi Zhang; Lin Zhang; Jack Ho Wong; Yau Sang Chan; Wen Liang Pan; Xiu Li Dan; Cui Ming Yin; Chi Hin Cho; Tzi Bun Ng
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

7.  Antioxidant activities of saponins extracted from Radix Trichosanthis: an in vivo and in vitro evaluation.

Authors:  Ying Chen; Yonghong Miao; Liyong Huang; Juxiang Li; Haiyan Sun; Yuanzeng Zhao; Jing Yang; Wenke Zhou
Journal:  BMC Complement Altern Med       Date:  2014-03-05       Impact factor: 3.659

8.  A Case of Stage IV Non-Small Cell Lung Cancer Treated with Korean Medicine Therapy Alone.

Authors:  Dong-Hyun Lee; Shin Seong; Sung-Su Kim; Jae-Bok Han
Journal:  Case Rep Oncol       Date:  2013-11-15

9.  Trichosanthin enhances sensitivity of non-small cell lung cancer (NSCLC) TRAIL-resistance cells.

Authors:  Chengcheng You; Yingming Sun; Shiyu Zhang; Guiliang Tang; Nannan Zhang; Chunyang Li; Xiaoli Tian; Shijing Ma; Yuan Luo; Wenjie Sun; Feng Wang; Xuefeng Liu; Yu Xiao; Yan Gong; Junhong Zhang; Conghua Xie
Journal:  Int J Biol Sci       Date:  2018-02-09       Impact factor: 6.580

10.  Fordin: A novel type I ribosome inactivating protein from Vernicia fordii modulates multiple signaling cascades leading to anti-invasive and pro-apoptotic effects in cancer cells in vitro.

Authors:  Weili Lu; Yingji Mao; Xue Chen; Jun Ni; Rui Zhang; Yuting Wang; Jun Wang; Lifang Wu
Journal:  Int J Oncol       Date:  2018-07-04       Impact factor: 5.650

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.